Vesalius Biocapital Partners
Venture capitalLuxembourg · Seed–Late Stage · 5 people tracked
Investment thesis
Vesalius Biocapital Partners invests in the human health sector through venture capital funds first raised in 2007, focusing on three areas: therapeutics, medical devices, and diagnostics. The firm typically acts as lead investor in most of its financing rounds and supports companies across all development stages, including relatively early-stage projects backed by proprietary technology, strong IP, distinctive team skills, and a clear competitive edge grounded in solid data. Its portfolio companies are based in Europe, enabling close interaction with management teams.
Source: firm website, verified Aug 3, 2026.
Team · 5 people
from the firm's website
What they invest in
from 8 of 21 portfolio companiesBiotech ×6Healthtech ×5Medical Devices ×3Digital Health ×2AI & Machine Learning ×1Deep Tech ×1SaaS ×1
HQs:Canada×1Germany×1
Investments · 21 tracked
founders shown can be your intro pathComplix develops Cell Penetrating Alphabodies, a protein-based therapeutic platform designed to target intracellular disease targets that are inaccessible to conventional antibodies and small molecule drugs.
Biotech
Co-investorsAndera Partners
Exact Imaging develops the ExactVu micro-ultrasound platform used for high-resolution prostate imaging and prostate cancer detection.
Digital HealthHealthtechMedical Devices
Randy AuCoin(President & CEO)
Co-investorsiGan PartnersLumira VenturesPMVVenture Ontario
Genkyotex was a developer of NOX inhibitor therapeutics, now owned by Calliditas Therapeutics AB.
Biotech
Co-investorsAndera PartnersMC Healthcare Ventures
Genomic Vision is a genome analysis company whose Molecular Combing technology characterizes DNA at single-molecule resolution for quality control in bioproduction and cell and gene therapy, as well as for drug discovery research.
AI & Machine LearningBiotechMedical Devices
Aaron Bensimon(Chairman of the Executive Board)Florence Allouche(Chairman of the Supervisory Board)
Humedics develops the LiMAx test, a diagnostic used to measure liver function and support clinical decision-making.
BiotechHealthtechMedical Devices
Ncardia develops human induced pluripotent stem cell (iPSC) technology, offering iPSC-derived cell models, screening assays, and custom services to support drug, gene, and cell therapy development.
BiotechDeep TechHealthtech
Co-investorsCapricorn Venture Partners
OMEICOS develops small-molecule therapies based on omega-3 fatty acid metabolism that target cell-protective pathways to treat cardiovascular, inflammatory, and mitochondrial diseases.
BiotechHealthtech
Co-investorsRemiges Ventures, Inc.Forbion
Voluntis provides a regulated digital health platform for pharmaceutical and medtech companies to build and manage patient-facing solutions across the patient journey, including symptom management, adherence and dosage support.
Digital HealthHealthtechSaaS
Co-investorsEisai Innovation, Inc.KaristaSanofi Ventures
Frequently asked questions
- How many investments has Vesalius Biocapital Partners made?
- Vesalius Biocapital Partners has 21 tracked investments.
- What stage does Vesalius Biocapital Partners invest at?
- Vesalius Biocapital Partners invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is Vesalius Biocapital Partners's typical check size?
- Vesalius Biocapital Partners typically writes checks of $11M.
- What sectors does Vesalius Biocapital Partners focus on?
- Vesalius Biocapital Partners focuses on Biotech, Digital Health, FoodTech, Healthtech, Medical Devices.
- Where is Vesalius Biocapital Partners located?
- Vesalius Biocapital Partners is headquartered in Luxembourg, LU.
- Does Vesalius Biocapital Partners lead rounds?
- Yes, Vesalius Biocapital Partners leads investment rounds.
- Who does Vesalius Biocapital Partners co-invest with?
- Vesalius Biocapital Partners most often shares deals with Andera Partners, Capricorn Venture Partners, Lumira Ventures, among 12 tracked co-investors.
Media · Podcasts & interviews
featuring the teamThe Value Creators with Fabienne Roussel & Guy Geldhof (Vesalius Biocapital Partners)
LPEA Luxembourg · Guy Geldhof
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.
Arkin Capital is a multi-asset manager overseeing more than $2 billion across venture capital, private equity, hedge funds, and real estate, operating through four arms: Arkin Health, Arkin Equity, Arkin Tech, and Arkin Real Estate.
MaRS is a Toronto-based innovation hub and accelerator that supports Canadian startups from pre-seed funding through international expansion, offering workspace, mentorship, investor and customer connections, and sector-focused programming.
The Business Development Bank of Canada (BDC) is a Canadian institution that has supported small and medium-sized businesses for over 80 years, providing financing and advisory services to entrepreneurs across all industries and growth stages.